Schizophrenia Trial, Recruiting NCT07091344 Sponsor: Fundació Sant Joan de Déu Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT07091344
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 years or older
  • People who have been diagnosed with a schizophrenia spectrum disorder according to standard diagnostic guidelines (DSM-5)
  • People who have been hearing voices persistently for at least 3 months, at a level that meets a specific threshold on a standard clinical rating scale
  • People whose psychiatric medication dose has been stable for at least 4 weeks before joining the trial
  • People who are fluent in Spanish, as that is the language used at the trial site
  • People who are able to understand the trial and agree to take part
  • People who are already receiving regular ongoing psychiatric care

Who may not be able to join:

  • People who are not able to identify one main or dominant voice they hear, as this is required for the therapy used in the trial
  • People with an intellectual disability based on their medical history
  • People currently struggling with active substance misuse
  • People with a brain injury or neurological condition that affects thinking and cognitive abilities
  • People with severe vision problems that would prevent them from using virtual reality (VR) technology
  • People who have a strong dislike of virtual reality, or who have previously experienced motion sickness or discomfort from VR simulators
  • People who are currently experiencing thoughts of suicide or are considered to be at risk
  • People who are not able or willing to follow the study procedures

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +34936406350

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Fundació Sant Joan de Déu
Registry
ClinicalTrials.gov
Start date
1 March 2024
Est. completion
30 September 2026

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Change in Emotion Recognition Score; Change in Executive Functioning Score; Change in Attributional Style Score; Change in Theory of Mind Score; Change in Metacognition Score; Change in Cognitive Flexibility Score; Change in Global Cognitive Performance Score; Change in Working Memory Score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov